Literature DB >> 1112809

Heterogeneity of human hepatic H-acetyl-beta-D-hexosaminidose. A activity toward natural glycosphingolipid substrates.

G Bach, K Suzuki.   

Abstract

A crude soluble preparation of human hepatic N-acetyl-beta-D-hexosaminidase was examined for its activities toward three natural glycosphingolipid substrates after fractionation by the isoelectric focusing procedure. Profiles of activities toward N-acetylgalactosaminyl-galactosyl-glucosylceramide (asialo GM2-ganglioside) and N-acetylgalactosaminyl-galactosyl-galactosyl-glucosylceramide (globoside) were always identical with that of nonspecific N-acetyl-beta-D-hexosaminidase as determined with artificial substrates. The Component A of the enzyme had the activity peak at an isoelectric point of 5.0 to 5.1. In contrast, hydrolytic activities toward N-acetylgalactosaminyl-[N-acetylneuraminyl]galactosyl- glucosylceramide (GM2-ganglioside) were associated with only the most acidic subfraction of the hexosaminidase A component. The activity to hydrolyze GM2-ganglioside had its peak at an isoelectric point of 4.8 to 4.9. These findings might provide an explanation for the GM2-ganglioside accumulation in juvenile GM2-gangliosidosis (partial deficiency of hexosaminidase A) and in the so-called AB variant of GM2-gangliosidosis (apparently normal hexosaminidase A and B activity).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1112809

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 2.  Glycosphingolipid hydrolases: properties and molecular genetics.

Authors:  M Wan Ho; A G Norden; J A Alhadeff; J S O'Brien
Journal:  Mol Cell Biochem       Date:  1977-10-07       Impact factor: 3.396

3.  Low levels of beta hexosaminidase A in healthy individuals with apparent deficiency of this enzyme.

Authors:  R Navon; B Geiger; Y B Yoseph; M C Rattazzi
Journal:  Am J Hum Genet       Date:  1976-07       Impact factor: 11.025

Review 4.  The biochemical genetics of the hexosaminidase system in man.

Authors:  E Beutler
Journal:  Am J Hum Genet       Date:  1979-03       Impact factor: 11.025

5.  GM2-gangliosidosis, AB variant: clinico-pathological study of a case.

Authors:  C M de Baecque; K Suzuki; I Rapin; A B Johnson; D L Whethers
Journal:  Acta Neuropathol       Date:  1975-12-19       Impact factor: 17.088

6.  Human lysosomal genes: arylsulfatase A and beta-galactosidase.

Authors:  G A Bruns; B J Mintz; A C Leary; V M Regina; P S Gerald
Journal:  Biochem Genet       Date:  1979-12       Impact factor: 1.890

7.  Characterization of unusual hexosaminidase A (HEX A) deficient human mutants.

Authors:  J S O'Brien; L Tennant; M L Veath; C R Scott; W E Bucknall
Journal:  Am J Hum Genet       Date:  1978-11       Impact factor: 11.025

8.  Purification and properties of the hexosaminidase A-activating protein from human liver.

Authors:  P Hechtman; D LeBlanc
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

9.  Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.

Authors:  P Hechtman; Z Kachra
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

10.  A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.

Authors:  Rohita Sharma; Scott Bukovac; John Callahan; Don Mahuran
Journal:  Biochim Biophys Acta       Date:  2003-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.